ABVC BIOPHARMA, INC.
Ticker: 1173313
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY25 | Q3 FY24 | Q3 FY24 | Q2 FY24 | Q2 FY24 | Q1 FY24 | Q1 FY24 | Q3 FY23 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.80+105.1% | 0.39+0.0% | 0.39+225.0% | 0.12+0.0% | 0.12 | 0.00 | 0.00-100.0% | 0.02 |
| Total Income | 0.80+105.1% | 0.39+0.0% | 0.39+225.0% | 0.12+0.0% | 0.12 | 0.00 | 0.00-100.0% | 0.02 |
| EXPENSES | ||||||||
| Expenditure | 1.96+184.1% | 0.69+102.9% | 0.34-68.8% | 1.09+11.2% | 0.98-71.6% | 3.45+21.5% | 2.84+30.9% | 2.17 |
| Tax | 0.00 | 0.00 | 0.00+100.0% | -0.11+0.0% | -0.11 | — | — | 0.00 |
| PROFIT | ||||||||
| PBT | -1.29-163.3% | -0.49-276.9% | -0.13+90.6% | -1.38-19.0% | -1.16+70.9% | -3.98-35.8% | -2.93+13.1% | -3.37 |
| Net Profit | -1.25-220.5% | -0.39-105.3% | -0.19+81.2% | -1.01-7.4% | -0.94+76.1% | -3.93-38.9% | -2.83+14.8% | -3.32 |
| KEY METRICS | ||||||||
| OPM % | -100.00%-22.34pp | -77.66%-90.49pp | 12.83%+112.83pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00%-52.07pp | -47.92%+52.07pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.05-66.7% | -0.03-50.0% | -0.02+77.8% | -0.09-12.5% | -0.08+80.0% | -0.40-37.9% | -0.29+64.6% | -0.82 |
Corporate Events
Board MeetingABVC
202628Oct
Board Meeting
Special meeting of stockholders to approve the 2026 Equity I…
SEC Filing ↗